Systems and methods for assessing disease risk, status, and prognosis
EP2812703A1
Risk factors and prediction of adverse events
AU2013207264A1
Use of galectin-3 for risk assessment and detection of preeclampsia and related conditions
TW201300110A
Inhibitors of GALECTIN-3 and methods of use thereof
WO2012106341A1
Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome
EP2588111A1
Statin therapy monitored by galectin- 3 measurement
WO2011116128A1
Methods for predicting cardiovascular events and monitoring treatment using pcsk9
MX2012005385A
Risk factors and prediction of myocardial infarction.
BR112012008063A2
galectin-3 and cardiac resynchronization therapy.
EP2359143A1
Galectin-3 immunoassay
JP2009133867A
Method and system for profiling biological system
EP2210108A2
Methods for detecting major adverse cardiovascular and cerebrovascular events
EP2200604A1
Methods of increasing sarcosine levels for treating schizophrenia
AU2008302489A1
Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione
WO2008118413A2
Methods for detecting coronary artery disease
EP1938231A1
Correlation analysis of biological systems
AU2006223068A1
Methods for detecting Alzheimer's disease
AU2005311954A1
Biological systems analysis
AU2004267806A1
Methods and systems for profiling biological systems
